Pure Global AI
NCT06037551Not yet recruiting

System Accuracy of the Blood Glucose Monitor for Personal Use Contour Care

Evaluierung Des Blutglukose Monitoring Systems Contour Care Der Firma Ascensia Diabetes Care Deutschland GmbH gemäß DIN EN ISO 15197:2015
Institut fur Diabetes Karlsburg GmbHClinicalTrials.govdiagnostic test
Study focus
Disease/Condition
Diabetes
Drug/Device/Intervention
blood glucose measuremen subject
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Institut fur Diabetes Karlsburg GmbH
Location
Karlsburg, Germany
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Nov 30, 2023
Enrollment
100 participants
Primary outcome

Analysis of system accuracy based on DIN EN ISO 15197

Summary

This study assesses the system accuracy of a blood glucose monitoring system in accordance
 with DIN EN ISO 15197:2015

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsOther specified diabetes mellitus without complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06037551
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06037551 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Not yet recruiting. The study focuses on Diabetes. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.